Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES PROCTER & GAMBLE HEALTH ZYDUS LIFESCIENCES/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 17.9 35.3 50.7% View Chart
P/BV x 2.1 9.7 21.9% View Chart
Dividend Yield % 0.7 3.2 22.1%  

Financials

 ZYDUS LIFESCIENCES   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
PROCTER & GAMBLE HEALTH
Jun-21
ZYDUS LIFESCIENCES/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs6747,500 9.0%   
Low Rs3314,004 8.3%   
Sales per share (Unadj.) Rs149.1607.7 24.5%  
Earnings per share (Unadj.) Rs22.7106.5 21.3%  
Cash flow per share (Unadj.) Rs29.7124.6 23.8%  
Dividends per share (Unadj.) Rs2.50130.00 1.9%  
Avg Dividend yield %0.52.3 22.0%  
Book value per share (Unadj.) Rs166.1421.6 39.4%  
Shares outstanding (eoy) m1,023.7416.60 6,167.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.49.5 35.6%   
Avg P/E ratio x22.154.0 40.9%  
P/CF ratio (eoy) x16.946.2 36.7%  
Price / Book Value ratio x3.013.6 22.2%  
Dividend payout %11.0122.1 9.0%   
Avg Mkt Cap Rs m514,27795,477 538.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7771,505 1,447.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,65210,087 1,513.3%  
Other income Rs m2,354181 1,300.6%   
Total revenues Rs m155,00610,268 1,509.6%   
Gross profit Rs m34,4272,460 1,399.4%  
Depreciation Rs m7,130300 2,373.5%   
Interest Rs m1,2708 15,875.0%   
Profit before tax Rs m28,3812,333 1,216.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,117565 906.0%   
Profit after tax Rs m23,2641,768 1,315.8%  
Gross profit margin %22.624.4 92.5%  
Effective tax rate %18.024.2 74.5%   
Net profit margin %15.217.5 87.0%  
BALANCE SHEET DATA
Current assets Rs m122,61410,389 1,180.3%   
Current liabilities Rs m78,3945,507 1,423.6%   
Net working cap to sales %29.048.4 59.9%  
Current ratio x1.61.9 82.9%  
Inventory Days Days93289 32.1%  
Debtors Days Days80215 37.1%  
Net fixed assets Rs m144,3829,390 1,537.7%   
Share capital Rs m1,024166 616.9%   
"Free" reserves Rs m168,9726,832 2,473.1%   
Net worth Rs m169,9966,998 2,429.1%   
Long term debt Rs m3,6210-   
Total assets Rs m266,99619,778 1,350.0%  
Interest coverage x23.3292.6 8.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 112.1%   
Return on assets %9.29.0 102.3%  
Return on equity %13.725.3 54.2%  
Return on capital %17.133.4 51.1%  
Exports to sales %00-   
Imports to sales %14.314.5 98.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,8691,462 1,495.6%   
Fx inflow Rs m63,0651,331 4,737.5%   
Fx outflow Rs m21,8691,462 1,495.6%   
Net fx Rs m41,196-131 -31,447.3%   
CASH FLOW
From Operations Rs m21,0412,473 851.0%  
From Investments Rs m11,544-323 -3,577.3%  
From Financial Activity Rs m-8,683-3,866 224.6%  
Net Cashflow Rs m23,729-1,716 -1,382.5%  

Share Holding

Indian Promoters % 74.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 14.9 14.5 102.3%  
FIIs % 2.9 6.5 44.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 48.2 52.1%  
Shareholders   455,624 65,729 693.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    LUPIN    


More on Cadila Healthcare vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Procter & Gamble Health Share Price Performance

Period Cadila Healthcare Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -1.78% -0.13% -0.46%
1-Month -7.14% -4.60% 0.65%
1-Year -37.11% -23.66% -13.70%
3-Year CAGR 13.13% -4.64% 20.93%
5-Year CAGR -5.84% 31.92% 10.98%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 74.9% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Procter & Gamble Health paid Rs 130.0, and its dividend payout ratio stood at 122.1%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.